Authors
Latest:
Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan ReexaminationMedicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.
Latest:
Edwin's Prescription Pharmacy: Servicing the Specialty Medication Needs of Long-Term Care PatientsOvercoming the challenges to meet the special needs of long-term care patients, this pharmacy provides a careful approach that provides positive results.
Latest:
Guidelines Recommend ACE Inhibitor or ARB for Heart FailureDr. Dutcher is a registered pharmacist based in Punta Gorda, Fla.
Latest:
Keep an Eye on Protein Kinase InhibitorsMedications in this drug class can alter the safety and efficacy of co-administered medications.
Latest:
Pharmacoeconomics of ColciGel for the Treatment of Acute Gout FlaresThe pharmacoeconomic impact of treating acute gout flares with ColciGel or with oralcolchicine.
Latest:
Drug Coverage and Decision Making in Medicare Part D EnrolleesThis pharmacy adjudication, prescription fulfillment study demonstrates how a sudden drop of prescription drug coverage has an effect on Medicare Part D patients' prescription decisions.
Latest:
Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and DiabetesA value-based benefit design program for prescription medications for asthma, hypertension, and diabetes could result in increased prescription use and decreased healthcare utilization and costs.
Latest:
New Challenges and Opportunities in Immunization Quality MetricsIn the United States, adult immunization rates are substandard. Opportunities exist to improve these rates trough quality performance measurement, but not without challenges.
Latest:
Five Major Issues Facing PharmacyHow these issues are handled will have a major impact on the future of pharmacy practice.
Latest:
Hepatitis C Treatment Duration Could Be Slashed for Some PatientsDirect-acting antivirals are a costly but highly-effective class of drugs for the treatment of hepatitis C that can cure most cases.
Latest:
Antidepressant Discontinuation: What the Tertiary Databases and Package Insert Tells YouDiscontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.
Latest:
Pharmacist Technicians Can Play Key Role in Push Toward Telemedicine During COVID-19 PandemicLessons from implementing electronic medical records should be heeded by allowing clinicians to focus on patient care and by delegating the management of telemedicine to support staff, such as pharmacy technicians.
Latest:
Catch Up with Highlights from ASCOTop news of the week from the annual meeting of the American Society of Clinical Oncology.
Latest:
Defining Your Pharmacy as a Wellness DestinationSuccessful pharmacists must be able to help themselves on both the business and clinical practice sides of the business.
Latest:
New Thinking Inside the Vial...Systems exist that enable storage of parenteral drugs in single-use vials for more than the 6 hours currently permitted, decreasing waste and increasing savings.
Latest:
Manage Acute Pain in Those Using OpioidsPharmacists play a vital role in managing regimens and ensuring proper compliance.
Latest:
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis PatientsAmong rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Latest:
The Impact of COVID-19 on Recent Pharmacy School GraduatesPharmacy students, particularly the graduating class of 2020, have been uniquely affected by the coronavirus disease 2019 (COVID-19) pandemic.
Latest:
Managing Complexity in OncologyRecently published data from a survey of commercial health plans reveal the latest trends and emerging strategies in oncology management.
Latest:
HCV Combo Effective Treating Patients With HIV Coinfection After Disease RecurrenceSofosbuvir, velpatasvir, and voxilaprevir successful in patients with hepatitis C virus infection, with and without HIV co-infection, including those with prior noncompletion of treatment or poor adherence to direct-acting antiviral drug regimens.
